122 related articles for article (PubMed ID: 1639820)
1. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.
Chamow SM; Kogan TP; Peers DH; Hastings RC; Byrn RA; Ashkenazi A
J Biol Chem; 1992 Aug; 267(22):15916-22. PubMed ID: 1639820
[TBL] [Abstract][Full Text] [Related]
2. Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).
Flasher D; Konopka K; Chamow SM; Dazin P; Ashkenazi A; Pretzer E; Düzgünes N
Biochim Biophys Acta; 1994 Aug; 1194(1):185-96. PubMed ID: 8075135
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
4. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
Moore JP; McKeating JA; Huang YX; Ashkenazi A; Ho DD
J Virol; 1992 Jan; 66(1):235-43. PubMed ID: 1727487
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
Borchers C; Tomer KB
Biochemistry; 1999 Sep; 38(36):11734-40. PubMed ID: 10512629
[TBL] [Abstract][Full Text] [Related]
7. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
Moore JP; McKeating JA; Norton WA; Sattentau QJ
J Virol; 1991 Mar; 65(3):1133-40. PubMed ID: 1995942
[TBL] [Abstract][Full Text] [Related]
8. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Moore JP; McKeating JA; Weiss RA; Sattentau QJ
Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.
Fu YK; Hart TK; Jonak ZL; Bugelski PJ
J Virol; 1993 Jul; 67(7):3818-25. PubMed ID: 8510207
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
[TBL] [Abstract][Full Text] [Related]
13. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
Moore JP
AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
[TBL] [Abstract][Full Text] [Related]
14. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
Brighty DW; Rosenberg M; Chen IS; Ivey-Hoyle M
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7802-5. PubMed ID: 1909031
[TBL] [Abstract][Full Text] [Related]
15. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
17. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA
Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
Hager-Braun C; Tomer KB
Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
[TBL] [Abstract][Full Text] [Related]
20. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
